SKI Market

Indian Indices

Sensex

85,241.32 20.72
( 0.02%)

Global Indices

Nasdaq

48,085.52 -302.55
(-0.63%)

Dow Jones

6,867.73 -49.51
(-0.72%)

Hang Seng

50,384.39 -142.53
(-0.28%)

Nikkei 225

9,931.38 -9.33
(-0.09%)

Forex

USD-INR

89.84 -0.06
(-0.06%)

EUR-INR

105.67 -0.12
(-0.11%)

GBP-INR

121.20 -0.12
(-0.10%)

JPY-INR

0.58 0.00
(-0.05%)

YOU ARE HERE :
HOME
Markets
Equity
Company News

EQUITY - MARKET SCREENER

Zydus Lifesciences Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

532321

INE010B01027

215.0764496

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

ZYDUSLIFE

19.07

92035.19

EPS(TTM)

Face Value()

Div & Yield %

47.96

1.2

Date	Headline
23-Dec-2025	Zydus partners with Bioeq for licensing, supply and commercialization of Lucentis® in US market
19-Dec-2025	Zydus signs agreement with Myriad Genetics
15-Dec-2025	Sentynl announces USFDA Acceptance of CUTX-101 NDA resubmission
10-Dec-2025	Zydus launches Zyrifa - a Denosumab biosimilar
10-Dec-2025	Zydus Lifesciences gains after launching Denosumab Biosimilar
04-Dec-2025	Zydus Lifesciences receives EIR for facility at Jarod, Vadodara
28-Nov-2025	Zydus Life gets US FDA nod for generic version of antidiabetic combination drug Glyxambi
26-Nov-2025	Stock Alert: Zydus Lifescience, United Breweries, Nelco, NCC, Refex Inds
26-Nov-2025	Zydus enters into licensing and commercialization agreement with RK Pharma Inc.
26-Nov-2025	Zydus Life rises after inking exclusive licensing deal with RK Pharma for US oncology product

<< < 1 2 3 ... > >>

85,241.32 20.72 ( 0.02%)

48,085.52 -302.55 (-0.63%)

6,867.73 -49.51 (-0.72%)

50,384.39 -142.53 (-0.28%)

9,931.38 -9.33 (-0.09%)

89.84 -0.06 (-0.06%)

105.67 -0.12 (-0.11%)

121.20 -0.12 (-0.10%)

0.58 0.00 (-0.05%)